Mark Cragg, PhDChair in Experimental Cancer Biology at University of SouthamptonSpeaker
Profile
Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the University of Southampton. His research concerns how therapeutics result in tumour regression with a focus on antibodies and small molecules, with a particular interest in Fc receptors and TNFR family members. The aim is to understand how these therapeutics delete tumour cells, how resistance occurs, and how it might be overcome.
Agenda Sessions
Engineering Antibodies for Agonism: From Fc to Fab
, 8:15amView Session